Preventing the Cancer Patient of Today From Becoming the Heart Failure Patient of Tomorrow∗

Preventing the Cancer Patient of Today From Becoming the Heart Failure Patient of Tomorrow∗

Bibliographic Details
Main Authors:	Derek M. Yellon, PhD, DSc, John Malcolm Walker, MD, Sapna Arjun, PhD
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Series:	JACC. CardioOncology
Subjects:	anthracycline cardiotoxicity heart failure remote ischemic pre-conditioning
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666087319300900

Similar Items

Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity
by: Derek J. Hausenloy, MD, PhD, et al.
Published: (2020-03-01)

An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study
by: Jukapun Yoodee, et al.
Published: (2021-08-01)

Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
by: Yu Kang, MD, PhD, et al.
Published: (2019-12-01)

MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review
by: Roberto Rosenfeld, et al.
Published: (2022-06-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

A journey in anthracycline-induced cardiotoxicity with emphasizing on doxorubicin: a review article
by: Atlasi Safaei, et al.
Published: (2021-11-01)

Anthracycline cardiomyopathy
by: Vasiliy Nefedovich Anokhin, et al.
Published: (2011-10-01)

The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity
by: Lori M. Minasian, MD, et al.
Published: (2019-09-01)

Cardiotoxicity: Importance of biomarkers
by: Kostadinović Jelena, et al.
Published: (2023-01-01)

Echocardiographic Changes after Treatment with Anthracyclines in Children
by: Hamid Amoozgar, et al.
Published: (2012-03-01)

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study
by: Prathana Nathan, et al.
Published: (2022-12-01)

Effects of sacubitril/valsartan in patients with cancer therapy-related heart failure
by: Marina V. Vitsenya, et al.
Published: (2023-09-01)

Cardiac events among patients with sarcoma treated with doxorubicin by method of infusion: A real‐world database study
by: Lee D. Cranmer, et al.
Published: (2023-01-01)

Risk and Management of Patients with Cancer and Heart Disease
by: Loreena Hill, et al.
Published: (2023-02-01)

Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know
by: Armando Ferrera, et al.
Published: (2023-05-01)

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01)

Electrocardiographic characteristics of Nigerian children on anthracycline-based chemotherapy: A preliminary report
by: I D Peter, et al.
Published: (2017-01-01)

Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study
by: Husam Abdel‐Qadir, et al.
Published: (2021-01-01)

Efficacy of Neurohormonal Therapies in Preventing Cardiotoxicity in Patients With Cancer Undergoing Chemotherapy
by: Muthiah Vaduganathan, MD, MPH, et al.
Published: (2019-09-01)

Baseline blood pressure and development of cardiotoxicity in patients treated with anthracyclines: A systematic review
by: Laura J. Philip, et al.
Published: (2022-12-01)

Case report: Evaluation of myocardial microcirculation in patients with breast cancer after anthracycline chemotherapy by using intravoxel incoherent motion imaging
by: Shilan Li, et al.
Published: (2022-09-01)

Association of Genetic Variants at TRPC6 With Chemotherapy-Related Heart Failure
by: Nadine Norton, et al.
Published: (2020-08-01)

Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse model
by: Cory V. Noel, et al.
Published: (2021-06-01)

Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
by: Stephen J. Foulkes, et al.
Published: (2020-07-01)

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
by: Yun Qiu, et al.
Published: (2023-12-01)

Left Ventricular Longitudinal Strain Abnormalities in Childhood Exposure to Anthracycline Chemotherapy
by: Arnaud Rique, et al.
Published: (2024-03-01)

Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application
by: Tanawat Attachaipanich, et al.
Published: (2023-02-01)

Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review
by: Izabela Koss-Mikołajczyk, et al.
Published: (2021-09-01)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023-01-01)

Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01)

Value of Left Ventricular Global Longitudinal Strain Assessed by Two-Dimensional Strain Imaging in Early Detection of Anthracycline Mediated Cardiotoxicity
by: Yasser Abdel-Hady, et al.
Published: (2022-04-01)

Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play
by: Maryam Moossavi, et al.
Published: (2023-03-01)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
by: Kara Annette Thompson
Published: (2018-03-01)

Skip Soft Definitions and Focus on Hard Endpoints∗
by: Juan C. Lopez-Mattei, MD, et al.
Published: (2019-12-01)

The effect of anthracyclines in minimal doses on cardiac function of children under chemotherapy
by: Shiva Rahimi Dehgolan, et al.
Published: (2014-07-01)

Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans
by: Caroline J. Zeiss, et al.
Published: (2019-08-01)

Cardio-oncology: need for novel structures
by: Lars Michel, et al.
Published: (2019-01-01)

Cardioprotective effect of thiotriazoline in cancer patients
by: A. V. Koltsov, et al.
Published: (2023-02-01)

Genetics of Anthracycline-Associated Cardiotoxicity
by: Talal Khalid Al-Otaibi, et al.
Published: (2022-04-01)

Clinical features of anthracycline‐induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single‐center, retrospective observational study
by: Takafumi Nakayama, et al.
Published: (2020-11-01)